|
General Information
|
|
|
Product
|
SOCS3 Peptide
|
|
Verified Applications
|
Immunocompetition, Immunodepletion
|
|
Peptide Description
|
Synthetic peptide taken within amino acid region 175-225 on human SOCS3 protein.
|
|
Accession #
|
GenBank: CAG46495
|
|
Physical Properties
|
|
|
Quantity
|
250 µg
|
|
Volume
|
100 µl
|
|
Form
|
Antigenic Blocking Peptide
|
|
Storage
|
-20⁰C for long term storage
|
|
Application Protocol
|
|
Competition/Depletion assay
|
Refer to competition assay protocol
|
|
Protein
|
|
Uniprot #
|
Q6FI39
|
|
Molecular Function
|
Protein modification; protein ubiquitination.
|
|
Subcellular Location
|
Cytoplasm
|
|
Expression
|
Widely expressed with high expression in heart, placenta, skeletal muscle, peripheral blood leukocytes, fetal and adult lung, and fetal liver and kidney. Lower levels in thymus.
|
|
Alternative Nomenclature
|
ATOD4 antibody
CIS 3 antibody
Cish3 antibody
Cytokine induced SH2 protein 3 antibody
E2a Pbx1 target gene in fibroblasts 10 antibody
EF 10 antibody
SOCS 3 antibody
SSI3 antibody
STAT induced STAT inhibitor 3 antibody
Suppressor of cytokine signaling 3 antibody
|
| |
|
SOCS3 Antibody
SOCS3 Antibody FITC
SOCS3 Antibody BIOTIN
SOCS3 Positive Control
